LS Berkshire Hathaway BRK-B Tracker ETP Securities vs Cigna Which Is More Profitable?

LS Berkshire Hathaway BRK-B Tracker ETP Securities and Cigna stocks are two distinct investment options in the financial market. While LS Berkshire Hathaway BRK-B Tracker ETP Securities provide investors with exposure to the performance of Berkshire Hathaway's BRK-B shares, Cigna stocks represent ownership in the healthcare company Cigna. Both assets come with their own set of risks and potential rewards, making them attractive to different types of investors. Understanding the differences between these two options can help investors make informed decisions about where to allocate their capital.

LS Berkshire Hathaway BRK-B Tracker ETP Securities or Cigna?

When comparing LS Berkshire Hathaway BRK-B Tracker ETP Securities and Cigna, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between LS Berkshire Hathaway BRK-B Tracker ETP Securities and Cigna.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. LS Berkshire Hathaway BRK-B Tracker ETP Securities has a dividend yield of 0%, while Cigna has a dividend yield of 2.12%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. LS Berkshire Hathaway BRK-B Tracker ETP Securities reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Cigna reports a 5-year dividend growth of 161.81% year and a payout ratio of 64.59%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with LS Berkshire Hathaway BRK-B Tracker ETP Securities P/E ratio at 0.00 and Cigna's P/E ratio at 37.52. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. LS Berkshire Hathaway BRK-B Tracker ETP Securities P/B ratio is 0.00 while Cigna's P/B ratio is 2.13.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, LS Berkshire Hathaway BRK-B Tracker ETP Securities has seen a 5-year revenue growth of 0.00%, while Cigna's is 2.37%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with LS Berkshire Hathaway BRK-B Tracker ETP Securities's ROE at 0.00% and Cigna's ROE at 5.59%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are €6.55 for LS Berkshire Hathaway BRK-B Tracker ETP Securities and $316.77 for Cigna. Over the past year, LS Berkshire Hathaway BRK-B Tracker ETP Securities's prices ranged from €6.55 to €6.55, with a yearly change of 0.00%. Cigna's prices fluctuated between $253.95 and $370.83, with a yearly change of 46.02%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.